SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-14-004474
Filing Date
2014-01-28
Accepted
2014-01-28 16:41:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-1 v366466_f-1a.htm F-1/A 96405
2 EXHIBIT 1.1 v366466_ex1-1.htm EX-1.1 193170
3 EXHIBIT 5.1 v366466_ex5-1.htm EX-5.1 39818
  Complete submission text file 0001144204-14-004474.txt   330466
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1/A | Act: 33 | File No.: 333-192783 | Film No.: 14553480
SIC: 2834 Pharmaceutical Preparations